RELX PLC (RELX)
- Previous Close
42.26 - Open
41.77 - Bid 41.47 x 900
- Ask 41.45 x 900
- Day's Range
41.19 - 41.86 - 52 Week Range
30.10 - 44.75 - Volume
1,352,995 - Avg. Volume
1,137,930 - Market Cap (intraday)
77.52B - Beta (5Y Monthly) 0.46
- PE Ratio (TTM)
35.41 - EPS (TTM)
1.17 - Earnings Date --
- Forward Dividend & Yield 0.74 (1.75%)
- Ex-Dividend Date May 2, 2024
- 1y Target Est
50.60
RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Scientific, Technical & Medical segment provides information and data sets that help researchers and healthcare professionals to advance science and health outcomes. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as increases the productivity. The Exhibitions segment is involved in the business that combines face-to-face with data and digital tools to help customers learn about markets, source products, and complete transactions. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.
www.relx.com34,675
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: RELX
Performance Overview: RELX
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: RELX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: RELX
Valuation Measures
Market Cap
77.73B
Enterprise Value
85.56B
Trailing P/E
36.29
Forward P/E
27.93
PEG Ratio (5yr expected)
3.71
Price/Sales (ttm)
7.09
Price/Book (mrq)
18.47
Enterprise Value/Revenue
9.34
Enterprise Value/EBITDA
25.83
Financial Highlights
Profitability and Income Statement
Profit Margin
19.44%
Return on Assets (ttm)
10.71%
Return on Equity (ttm)
49.72%
Revenue (ttm)
9.16B
Net Income Avi to Common (ttm)
1.78B
Diluted EPS (ttm)
1.17
Balance Sheet and Cash Flow
Total Cash (mrq)
155M
Total Debt/Equity (mrq)
188.92%
Levered Free Cash Flow (ttm)
1.71B
Research Analysis: RELX
Company Insights: RELX
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: RELX
Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover
In this edition, we explore Australian asset managers; PAB's revenue; and initiating coverage of RELX; and Lithium Americas, Persimmon, and Inwit.
Analyst Report: RELX PLC
RELX is a global provider of information-based analytics and decision tools for professional and business customers in various industries. The company serves sectors such as science and medical research, risk management, and legal. In addition, RELX organizes large-scale digital and face-to-face events such as industry trade shows. Around 60% of revenue is generated in North America and about 20% in Europe.
RatingPrice TargetAnalyst Report: RELX PLC
RELX, formerly known as Reed Elsevier, is a FTSE 100 diversified information and analytics company. The firm operates across four main areas: scientific, technical, and medical (37% of 2021 sales); risk (34%); legal (22%); and exhibitions (7%). RELX Group has three listings: its primary one in London and two more in New York and Amsterdam.
RatingPrice TargetAnalyst Report: RELX PLC
RELX, formerly known as Reed Elsevier, is a FTSE 100 diversified information and analytics company. The firm operates across four main areas: scientific, technical, and medical (37% of 2021 sales); risk (34%); legal (22%); and exhibitions (7%). RELX Group has three listings: its primary one in London and two more in New York and Amsterdam.
RatingPrice Target